Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3016)
All Articles published online
|
Nov 14, 2008 (publication date) through May 21, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Iacobellis A, Ippolito A, Andriulli A. Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition. World J Gastroenterol 2008; 14(42): 6467-6472 [PMID: 19030197 DOI: 10.3748/wjg.14.6467] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i42/6467.htm |
| Number | Citing Articles |
| 1 |
Paul Feuerstadt, Ari L. Bunim, Heriberto Garcia, Jordan J. Karlitz, Hatef Massoumi, Amar J. Thosani, Andrew Pellecchia, Allan W. Wolkoff, Paul J. Gaglio, John F. Reinus. Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients†. Hepatology 2010; 51(4): 1137 doi: 10.1002/hep.23429
|
| 2 |
Norberto C. Chávez-Tapia, Ezequiel Ridruejo, Angelo Alves de Mattos, Fernando Bessone, Jorge Daruich, Juan F. Sánchez-Ávila, Hugo Cheinquer, Rodrigo Zapata, Misael Uribe, Francisco Bosques-Padilla, Adrián Gadano, Alejandro Soza, Milagros Dávalos-Moscol, Claudio Marroni, Linda Muñoz-Espinoza, Graciela Castro-Narro, Raymundo Paraná, Nahum Méndez-Sánchez. An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver. Annals of Hepatology 2013; 12: S3 doi: 10.1016/S1665-2681(19)31404-8
|
| 3 |
Ayse Aytaman, Marina Kaufman, Norah A Terrault. Management of posttransplant hepatitis C infection. Current Opinion in Organ Transplantation 2010; 15(3): 301 doi: 10.1097/MOT.0b013e3283398237
|
| 4 |
José Velosa. Why is Viral Eradication so Important in Patients with HCV-Related Cirrhosis?. Antiviral Therapy 2017; 22(1): 1 doi: 10.3851/IMP3077
|
| 5 |
Josep Melero, Marina Berenguer. Antiviral therapy in patients with HCV-cirrhosis. Annals of Hepatology 2009; 8(4): 292 doi: 10.1016/S1665-2681(19)31741-7
|
| 6 |
Angelo Alves de Mattos, Ângelo Zambam de Mattos. Treatment of HCV infection in patients with cirrhosis. Annals of Hepatology 2010; 9: S80 doi: 10.1016/S1665-2681(19)31729-6
|
| 7 |
K Jurczyk, Ł Laurans, E Karpińska, M Wawrzynowicz-Syczewska, M Parczewski, A Boroń-Kaczmarska. Risk score based PEG Interferon alpha 2b and Ribavirin treatment response estimation model for genotype 1 chronic hepatitis C patients. Advances in Medical Sciences 2011; 56(2): 165 doi: 10.2478/v10039-011-0056-5
|
| 8 |
Lauren A. Beste, George N. Ioannou, Meaghan S. Larson, Michael Chapko, Jason A. Dominitz. Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication. Clinical Gastroenterology and Hepatology 2010; 8(11): 972 doi: 10.1016/j.cgh.2010.07.012
|
| 9 |
V. Virlogeux, P. Pradat, F. Bailly, G. Funingana, F. Gonçalves, M. Maynard, K. Hartig‐Lavie, M. Amiri, F. Zoulim. Boceprevir and telaprevir‐based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end‐stage liver disease score. Journal of Viral Hepatitis 2014; 21(9) doi: 10.1111/jvh.12237
|
| 10 |
R. Ackens, D. Posthouwer. Treatment of chronic hepatitis C with direct acting antiviral agents in patients with haemophilia, end‐stage liver disease and coinfected with HIV. Haemophilia 2016; 22(3) doi: 10.1111/hae.12899
|
| 11 |
Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Ewa Janczewska, Hanna Berak, Andrzej Horban, Marek Sitko, Aleksander Garlicki, Beata Dobracka, Agnieszka Czauż-Andrzejuk, Dorota Dybowska, Waldemar Halota, Małgorzata Pawłowska, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Włodzimierz Mazur, Zbigniew Deroń, Teresa Belica-Wdowik, Barbara Baka-Ćwierz, Iwona Buczyńska, Krzysztof Simon, Anna Piekarska, Jolanta Białkowska-Warzecha, Beata Lorenc, Rafał Krygier, Agnieszka Staniaszek, Jakub Klapaczyński, Jolanta Citko, Łukasz Socha, Marta Wawrzynowicz-Syczewska, Łukasz Laurans, Robert Flisiak. Interferon Free Therapy with and Without Ribavirin for Genotype 1 HCV Cirrhotic Patients in the Real World Experience. Hepatitis Monthly 2018; 18(8) doi: 10.5812/hepatmon.80761
|
| 12 |
Guillermo Cabrera Álvarez, Diana Gόmez-Galicia, Lourdes Rodríguez-Fragoso, Vicente Madrid Marina, Luis Cañedo Dorantes, Miguel Sánchez-Alemán, Nahum Méndez-Sánchez, Jorge Reyes Esparza. Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin. Annals of Hepatology 2011; 10(4): 458 doi: 10.1016/S1665-2681(19)31513-3
|
| 13 |
Alpna R. Limaye, Roberto J. Firpi. Management of Recurrent Hepatitis C Infection after Liver Transplantation. Clinics in Liver Disease 2011; 15(4): 845 doi: 10.1016/j.cld.2011.08.003
|
| 14 |
Antonio Massimo Ippolito, Angelo Iacobellis, Michele Milella, Fabio Conti, Vincenzo Messina, Maria Rosa Valvano, Grazia Anna Niro, Filomena Morisco, Michele Barone, Antonio Patrizio Termite, Giuseppina Brancaccio, Angelo Andriulli. Hepatitis C Virus Clearance in Older Adults. Journal of the American Geriatrics Society 2018; 66(1): 85 doi: 10.1111/jgs.15140
|
| 15 |
I. A. Narkevich, E. A. Tsitlionok. Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 2023; 16(4): 607 doi: 10.17749/2070-4909/farmakoekonomika.2023.193
|
| 16 |
Richard K. Sterling. Long-Term Effects of Sustained Virologic Response on the Development of Esophageal Varices in Compensated Cirrhosis: “Is the Bang Worth the Buck?”. Hepatology 2010; 51(6): 1891 doi: 10.1002/hep.23601
|
| 17 |
M. Guarino, F. Morisco, M. R. Valvano, A. M. Ippolito, M. Librandi, N. Andriulli, M. Greco, A. Amoruso, A. Iacobellis, G. Niro, N. Caporaso, A. Andriulli. Systematic review: interferon‐free regimens for patients with HCV‐related Child C cirrhosis. Alimentary Pharmacology & Therapeutics 2017; 45(9): 1193 doi: 10.1111/apt.14017
|
| 18 |
Magnhild Gangsøy Kristiansen, Tore Jarl Gutteberg, Liisa Mortensen, Leif Kyrre Berg, Rasmus Goll, Jon Florholmen. Clinical outcomes in a prospective study of community-acquired hepatitis C virus infection in Northern Norway. Scandinavian Journal of Gastroenterology 2010; 45(6): 746 doi: 10.3109/00365521003690699
|
| 19 |
Necati Örmeci, Hakan Erdem. Basic answers to complicated questions for the course of chronic hepatitis C treatment. Expert Review of Gastroenterology & Hepatology 2012; 6(3): 371 doi: 10.1586/egh.12.16
|
| 20 |
David R Scott, Miriam T Levy. Liver Transient Elastography (Fibroscan®): A Place in the Management Algorithms of Chronic Viral Hepatitis. Antiviral Therapy 2010; 15(1): 1 doi: 10.3851/IMP1474
|
| 21 |
Evangelos Stournaras, Georgios Neokosmidis, Dimitrios Stogiannou, Andreas Protopapas, Konstantinos Tziomalos. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis. European Journal of Gastroenterology & Hepatology 2018; 30(11): 1277 doi: 10.1097/MEG.0000000000001254
|